Protocolo de seguimiento de pacientes con fibrosis quística diagnosticados por cribado neonatal

  1. Silvia Gartner
  2. Pedro Mondéjar-López
  3. Óscar Asensio de la Cruz
Revue:
Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )

ISSN: 1695-4033 1696-4608

Année de publication: 2019

Volumen: 90

Número: 4

Pages: 251-251

Type: Article

DOI: 10.1016/J.ANPEDI.2018.11.009 DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )

Résumé

Newborn screening (NBS) for cystic fibrosis (CF) is well-established in many countries and provides the opportunity for an early diagnosis and treatment before the development of irreversible structural lung damage. In 1999, Catalonia, Castilla-León, and the Balearic Islands started the NBS programme for CF. In the last 10 years its implementation rapidly spread and all the autonomies offer the NBS programme for CF since 2015. There are many different strategies across Spain. It is believed that it is very opportune to have an updated and consensual guide for the diagnosis, follow-up, and treatment of patients diagnosed by neonatal screening.